A Review Study on Herbal Nutraceuticals: A Leading Edge in the Treatment of Neurological Disorders with the Help of Medicinal Plants

Jump To References Section

Authors

  • Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad – 201003, Uttar Pradesh ,IN
  • Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad – 201003, Uttar Pradesh ,IN
  • Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad – 201003, Uttar Pradesh ,IN
  • Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad – 201003, Uttar Pradesh ,IN
  • Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad – 201003, Uttar Pradesh ,IN

DOI:

https://doi.org/10.18311/jnr/2024/36026

Keywords:

Ayurveda, Herbal Nutraceuticals, Medicinal Plants, Neurodegenerative Disorders

Abstract

Neurodegenerative diseases are characterized by the loss and death of neurons with their structure and functions and this is causing a great burden on society at present time. The degeneration of neurons is caused due to a variety of factors which may be genetic, environmental, oxidative stress and many more. The scientific articles regarding neurodegenerative disorders, their classification, and mechanism of action are pooled from different scientific databases. We have used preferred reporting items for systemic reviewing of articles to filter those which are highly relevant and counter the information at present: neurodegenerative disorders, medicinal plants, herbal plants from neurodegeneration, and herbal nutraceuticals as summarized. As per the side effects caused by the use of synthetic drugs for the treatment of various neurological disorders, to reduce their efficacy, it was found the new advancement of herbal nutraceuticals has created havoc and has been reported to possess neuroprotective effects with minimized side effects. Medicinal plants for neuro-degenerative diseases have been documented to cure a variety of neurological disorders and their effects over synthetic drugs by the advancing use of herbal nutraceuticals. This review will provide the role of herbal nutraceuticals and medicinal plants in curing neurodegenerative diseases in the present era.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2024-05-28

How to Cite

Kabra, S., Priya, T., Basu, T., Bashir, T., & Sachdeva, M. (2024). A Review Study on Herbal Nutraceuticals: A Leading Edge in the Treatment of Neurological Disorders with the Help of Medicinal Plants. Journal of Natural Remedies, 24(5), 995–1004. https://doi.org/10.18311/jnr/2024/36026
Received 2023-12-31
Accepted 2024-03-21
Published 2024-05-28

 

References

Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, et al. Progress in gene therapy for neurological disorders. Nat Rev Neurol. 2013; 9(5):277-91. https://doi. org/10.1038/nrneurol.2013.56 PMid:23609618 PMCid: PM C 3908892

van den Heuvel MP, Sporns O. Network hubs in the human brain. Trends in Cognitive Sciences. 2013; 17(12):683-96. https://doi.org/10.1016/j.tics.2013.09.012 PMid:24231140

Ganat YM, Silbereis J, Cave C, Ngu H, Anderson GM, Ohkubo Y, et al. Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo. J Neurosci. 2006; 26(33):8609-21. https://doi.org/ 10.1523/JNEUROSCI.2532-06.2006 PMid:16914687 PM C id: PMC6674357

Kandel ER, Squire LR. Neuroscience: Breaking down scientific barriers to the study of brain and mind. Science. 2000; 290:1113-20. https://doi.org/10.1126/ science.290.5494.1113 PMid:11185010

Nathan DG, Fontanarosa PB, Wilson JD: Opportunities for medical research in the 21st century. The Journal of the American Medical Association. 2001; 285:533-4. https:// doi.org/10.1001/jama.285.5.533 PMid:11176853

Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2197-223. https://doi. org/10.1016/S0140-6736(12)61689-4 PMid:23245608

Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Cell Biol. 2000; 1(2):120-30. https://doi. org/10.1038/35040009 PMid:11253364

Hinge NS, Kathuria H, Pandey MM. Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Appl Mater Today. 2022; 26. https://doi. org/10.1016/j.apmt.2021.101303

Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. BioMed Research International. 2014; 2014:1-10. https://doi.org/ 10 .11 55/2014/474296 PMid:25101284 PMC id: PM C 41 01 992

Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010; 13(7):805– 11. https://doi.org/10.1038/nn.2575 PMid:20581 817 PMC id:PMC4038747

Aizenman E, Mastroberardino PG. Metals and neurodegeneration. Neurobiol Dis. 2015; 81:1–3. https:// doi.org/10.1016/j.nbd.2015.08.012 PMid:26542885 PMC id :PMC4793913

Rasool M, Malik A, Qureshi MS, Manan A, Pushparaj PN, Asif M, et al. Recent updates in the treatment of neurodegenerative disorders using natural compounds. evidence-based complementary and alternative medicine. 2014; 2014:1–7. https://doi.org/10.1155/2014/979730 P M id: 248 64161 PMCid:PMC4017872

Paoli A. Canato M. Toniolo L, Bargossi AM, Ner M, Alesso D, et al. The ketogenic diet: an underappreciated therapeutic option? La ClinicanTerapeutica. 2011; 162(5):e145-53.

Kouli A, Torsney KM, Kuan WL. Parkinson's disease: Etiology, neuropathology, and pathogenesis. Parkinson's Disease: Pathogenesis and Clinical Aspects. 2018; 1(1):3-26.

https://doi.org/10.15586/codonpublications.parkinsonsdis ea se.2018.ch1 PMid:30702842

Jellinger KA. Basic mechanisms of neurodegeneration: A critical update. J Cell Mol Med. 2010; 14(3). https://doi. org/10.1111/j.1582-4934 .201 0 .0 10 10.x PMid:20070435 PMCid: PMC3823450

Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. Mol Neurodegener. 2020; 15(1). https://doi.org/10.1186/s13024-020-00391-7 PMid:32677986 PMCid:PMC7364557

Liu Y, Yin H, Chen K. Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicine. Sci China Life Sci. 2013; 56(11):1000–6. https://doi. org/10.1007/s11427-013-4551-8 PMid:24114444

Bakhru HK. Herbs that heal. Natural remedies for good health. New Delhi, India: Orient Paperbacks; 2001. p. 17.

Mook-Jung I, Shin JE, Yun SH, et al. Protective effects of asiaticoside derivatives against beta amyloid neurotoxicity. J Neurosci Res. 1999; 58:417-25.

Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008; 9:369-74. https://doi.org/10.1007/ s10522-008-9185-z PMid:18931935

Kuboyama K, Thoda C, Komatsu K, Effects of Ashwagandha (Roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull. 2014; 37(6):892-97. https://doi. org/10.1248/bpb.b14-00022 PMid: 24882401

Kumar A, Kulkarni SK, Effect of BR-16A (Mentat) a polyherbal formulation on drug-induced catalepsy in mice. Indian Journal of Experimental Biology. 2016; 44(1): 45-8.

Kulkarni SK, Sharma A, Verma A, Ticku MK. GABA receptor mediated anticonvulsant action of Withania somnifera root extract. Indian Drugs. 1993:305-312.

Nagashayana N, Sankarankutty P, Nampoothiri MR, et al. Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease. J Neurol Sci. 2000; 176(2):124-127.

Gupta SC, Prasad S, Tyagi AK, Kunnumakkara AB, Aggarwal BB. Neem (Azadirachta indica): An Indian traditional panacea with modern molecular basis. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology. 2017; 34:14–20. https://doi. org/10.1016/j.phymed.2017.07.001 PMid:28899496

Moneim AA. Azadirachta indica attenuates cisplatin-induced neurotoxicity in rats. Indian J Pharmacol. 2014; 46(3). https://doi.org/10.4103/0253-7613.132182 PMid:24987180 PMCid:PMC4071710

Jaiswal AK, Bhattacharya SK, Acharya SB. Anxiolytic activity of Azadirachta indica leaf extract in rats. Indian Journal of Experimental Biology. 1994; 32(7):489-91.

Dash SP, Dixit S, Sahoo S. Phytochemical and biochemical characterizations from leaf extracts from Azadirachta indica: an important medicinal plant. Biochemistry and Analytical Biochemistry. 2017; 06(02). https://doi.org/10.4172/2161- 1009.1000323

Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine. 2005; 12(4):305-17. https://doi.org/10.1016/j.phymed.2003.12.008 PMid: 15 898709

Singh H, Dhawan B. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian J Pharmacol. 1997; 29:S359-65.

Basu N, Rastogi R, Dhar ML. Chemical examination of Bacopa monniera Wettst Part IIIBacoside B. India J Chem. 1967; 5:84-95.

Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature. 2000; 404(6776):394-8. https://doi. org/10.1038/35006074 PMid:10746727

Zhou Y, Shen YH, Zhang C, Su J, Liu RH, Zhang WD. Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models. J Nat Prod. 2007; 70(4):652-5. https://doi.org/10.1021/np060470s PMid: 17343408

Houghton PJ, Raman A. Laboratory handbook for fractionation of natural extracts. London: Chapman and Hall; 1998; p. 199. https://doi.org/10.1007/978-1-4615- 5809-5

Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Pharmacol. 1992; 34(4):352-8. https:// doi.org/10.1111/j.1365-2125.1992.tb05642.x PMid:1457269 PMCid:PMC1381419

Kumar GP, Khanum F. Neuroprotective potential of phytochemicals. Pharmacog Rev. 2012; 6(12): 81-90. https://doi.org/10.4103/0973-7847.99898 PMid: 23055633 PMCid: PMC3459459

Biesalaki HK. Nutraceuticals: The link between nutrition and medicine. In: Kramer K, Hoppe PP, Packer L, editors. Nutraceuticals in health and disease prevention. New York, Marcel Dekker Inc.; 2001. p. 1-26.

Das L, Bhaumik E, Raychaudhuri U, Chakraborty R. Role of nutraceuticals in human health. Journal of Food Science and Technology. 2011; 49(2):173-83. https://doi.org/10.1007/ s13197-011-0269-4 PMid:23572839 PMCid:PMC3550857

Sachdeva V, Roy A, Bharadvaja N. Current prospects of nutraceuticals: A review. Curr Pharm Biotechnol. 2020; 21(10):884-96. https://doi.org/10.2174/1389201021666200 130113441 PMid:32000642

Frisardi V, Panza F, Solfrizzi V, Seripa D, Pilotto A. Plasma lipid disturbances and cognitive decline. Journal of the American Geriatrics Society. 2010; 58(12):2429-30. https:// doi.org/10.1111/j.1532-5415.2010.03164.x PMid:21143446

Colín-González AL, Ali SF, Túnez I, Santamaría A. On the antioxidant, neuroprotective and anti-inflammatory properties of S-allyl cysteine: An update. Neurochem Int. 2015; 89:83-91. https://doi.org/10.1016/j. neuint.2015.06.011 PMid:26122973

Grassi D, Ferri C, Desideri G. Brain protection and cognitive function: Cocoa flavonoids as nutraceuticals. Curr Pharm Des. 2015; 22(2):145-51. https://doi.org/10.2174/13816128 22666151112145730 PMid:26561075

Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. International Union of Biochemistry and Molecular Biology: Life. 2001; 52(3-5):159-64. https://doi. org/10.1080/15216540152845957 PMid:11798028

Manap ASA, Vijayabalan S, Madhavan P, Chia YY, Arya A, Wong EH, et al. Bacopa monnieri, a neuroprotective lead in Alzheimer disease: A review on its properties, mechanisms of action, and preclinical and clinical studies. Drug Target Insights. 2019; 13. https://doi. org/10.1177/1177392819866412 PMid:31391778 PMCid: PM C 6669844